Radioguided and fluorescence-guided surgery should be an additional treatment option for PCa patients, in this direction PSMA ligands for radio-/fluorescence-guided surgery and/or targeted photodynamic therapy are being investigated. Here, FOLH1 is linked to posterior cortical atrophy.